Cervical cancer jab effect underestimated15th July 2010
The UK’s cervical cancer immunisation programme may offer better protection than initially thought.
Research by the Health Protection Agency, the University of Manchester and the Manchester Royal Infirmary found the strains of human papillomavirus (HPV) targeted by the vaccine are responsible for a higher number of cases than expected.
The researchers have found that HPV 16 and 18 are actually responsible for between 73% and 77% of cases, suggesting that the vaccine could slash rates from about 3,000 to less than 700 a year.
Share this page
There are no comments for this article, be the first to comment!
Post your comment
Only registered users can comment. Fill in your e-mail address for quick registration.
Title: Cervical cancer jab effect underestimated
Author: Mark Nicholls
Article Id: 15508
Date Added: 15th Jul 2010